Genetic Profile of the Dystrophin Gene Reveals New Mutations in Colombian Patients Affected with Muscular Dystrophinopathy

Paula Triana-Fonseca,1 Juan Fernando Parada-Márquez,1 Claudia T Silva-Aldana,2 Daniela Zambrano-Arenas,1 Laura Lucia Arias-Gomez,2 Natalia Morales-Fonseca,3 Esteban Medina-Méndez,2 Carlos M Restrepo,4 Daniel Felipe Silgado-Guzmán,2 Dora Janeth Fonseca-Mendoza4 1Facultad de Medicina, Universidad del...

Full description

Bibliographic Details
Main Authors:	Triana-Fonseca P, Parada-Márquez JF, Silva-Aldana CT, Zambrano-Arenas D, Arias-Gomez LL, Morales-Fonseca N, Medina-Méndez E, Restrepo CM, Silgado-Guzmán DF, Fonseca-Mendoza DJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-10-01
Series:	The Application of Clinical Genetics
Subjects:	duchenne-becker muscular dystrophy dmd mlpa next-generation sequencing target molecular therapy exon skipping mutation
Online Access:	https://www.dovepress.com/genetic-profile-of-the-dystrophin-gene-reveals-new-mutations-in-colomb-peer-reviewed-fulltext-article-TACG

Similar Items

Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies
by: Gisela Gaina, et al.
Published: (2021-12-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
by: Mariko Okubo, et al.
Published: (2017-08-01)

The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine
by: Kristy Iskandar, et al.
Published: (2019-10-01)

Comprehensive Molecular Analysis of <i>DMD</i> Gene Increases the Diagnostic Value of Dystrophinopathies: A Pilot Study in a Southern Italy Cohort of Patients
by: Fatima Domenica Elisa De Palma, et al.
Published: (2021-10-01)

The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47
by: Christopher R. Heier, et al.
Published: (2023-04-01)

A Genotype-Phenotype Correlation Study of Exon Skip-Equivalent In-Frame Deletions and Exon Skip-Amenable Out-of-Frame Deletions across the <i>DMD</i> Gene to Simulate the Effects of Exon-Skipping Therapies: A Meta-Analysis
by: Saeed Anwar, et al.
Published: (2021-01-01)

Identification of Exonic Copy Number Variations in Dystrophin Gene Using Mlpa / Identificarea Variaţiilor Numărului de Copii în Gena Distrofinei Folosind Metoda Mlpa
by: Rusu Cristina, et al.
Published: (2014-12-01)

Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients [version 3; peer review: 2 approved]
by: Kristy Iskandar, et al.
Published: (2023-11-01)

Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
by: Juan-Mateu Jonàs, et al.
Published: (2012-10-01)

Molecular Characterization of Dystrophin Gene in Iraqi Patients with Muscular Dystrophy.
by: Areen T. Ramadhan Al-Hadithi, et al.
Published: (2014-07-01)

Comprehensive genetic characteristics of dystrophinopathies in China
by: Peipei Ma, et al.
Published: (2018-07-01)

Systemic administration of the antisense oligonucleotide NS‐089/NCNP‐02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial
by: Takami Ishizuka, et al.
Published: (2023-06-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
by: Remko Goossens, et al.
Published: (2023-12-01)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01)

A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review
by: Lam Chung Liang, et al.
Published: (2022-03-01)

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
by: Yusuke Echigoya, et al.
Published: (2018-12-01)

Early myocardial damage assessment in dystrophinopathies using 99Tcm-MIBI gated myocardial perfusion imaging
by: Zhang L, et al.
Published: (2015-12-01)

Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy
by: Akinori Nakamura
Published: (2019-03-01)

MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
by: Sekar Deepha, et al.
Published: (2017-06-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014-01-01)

Duchenne's/Becker's muscular dystrophy: Analysis of genotype-feno-type correlation in 28 patients
by: Keckarević Milica, et al.
Published: (2002-01-01)

Peptide Nucleic Acid Promotes Systemic Dystrophin Expression and Functional Rescue in Dystrophin-deficient mdx Mice
by: Xianjun Gao, et al.
Published: (2015-01-01)

The dystrophinopathies in Costa Rica
by: Jorge Azofeifa
Published: (2004-09-01)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
by: HaiFang Yin, et al.
Published: (2013-01-01)

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model
by: Liubov V. Gushchina, et al.
Published: (2023-12-01)

Alu-Mediated Insertions in the <i>DMD</i> Gene: A Difficult Puzzle to Interpret Clinically
by: Annalaura Torella, et al.
Published: (2023-05-01)

Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy
by: Alberto Malerba, et al.
Published: (2012-01-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
by: Nicolas Wein, et al.
Published: (2022-09-01)

Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated DMD exon 2 skipping
by: Tabatha R. Simmons, et al.
Published: (2021-06-01)

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
by: Francesco Galli, et al.
Published: (2024-03-01)

A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data
by: Zhihao Xie, et al.
Published: (2024-02-01)

Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies
by: Kenji Rowel Q. Lim, et al.
Published: (2020-07-01)

Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India
by: Mandava V Rao, et al.
Published: (2014-01-01)

"Molecular Analysis of Iranian Patients with Duchenne/Becker Muscular Dystrophies"
by: S Kheradmand kia, et al.
Published: (2003-09-01)

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
by: Kane Greer, et al.
Published: (2020-06-01)

Next-generation sequencing approach to molecular diagnosis of Iranian patients with Duchenne/Becker muscular dystrophy: Several novel variants identified
by: MohammadKazem Bakhshandeh, et al.
Published: (2023-03-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012-01-01)

Advances in Dystrophinopathy Diagnosis and Therapy
by: Fawzy A. Saad, et al.
Published: (2023-08-01)